Evidence map›Paper›PMID 29386057›Full record

ArticleStem cell research & therapy2018

Delivery of VEGFA in bone marrow stromal cells seeded in copolymer scaffold enhances angiogenesis, but is inadequate for osteogenesis as compared with the dual delivery of VEGFA and BMP2 in a subcutaneous mouse model.

Sunita Sharma, Dipak Sapkota, Ying Xue, Saroj Rajthala, Mohammed A Yassin, Anna Finne-Wistrand, Kamal Mustafa

Open access · goldAbstract readComparative Study
In one paragraph

Article in Stem cell research & therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Extracellular vesicles: From bone development to regenerative orthopedics.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. [Research progress ofZhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2021
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Sunita SharmaDepartment of Clinical Dentistry, Centre for Clinical Dental Research, University of Bergen, 5020, Bergen, Norway. Sunita.sharma@iko.uib.no.
Dipak SapkotaDepartment of Oral Biology, Faculty of Dentistry, University of Oslo, 0316, Oslo, Norway.
Ying XueDepartment of Clinical Dentistry, Centre for Clinical Dental Research, University of Bergen, 5020, Bergen, Norway.
Saroj RajthalaThe Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway.
Mohammed A YassinDepartment of Fibre and Polymer Technology, KTH Royal Institute of Technology, 10044, Stockholm, Sweden.
Anna Finne-WistrandDepartment of Fibre and Polymer Technology, KTH Royal Institute of Technology, 10044, Stockholm, Sweden.
Kamal MustafaDepartment of Clinical Dentistry, Centre for Clinical Dental Research, University of Bergen, 5020, Bergen, Norway. kamal.mustafa@iko.uib.no.
University of Bergen · NOKTH Royal Institute of Technology · SEUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn bone tissue engineering (BTE), extensive research into vascular endothelial growth factor A (VEGFA)-mediated angiogenesis has yielded inconsistent results. The aim of this study was to investigate the influence on angio- and osteogenesis of adenoviral-mediated delivery of VEGFA alone or in combination with bone morphogenetic protein 2 (BMP2) in bone marrow stromal cells (BMSC) seeded onto a recently developed poly(LLA-co-CL) scaffold.

methodsHuman BMSC were engineered to express VEGFA alone or in combination with BMP2 and seeded onto poly(LLA-co-CL) scaffolds. Changes in angiogenic and osteogenic gene and protein levels were examined by quantitative reverse-transcription polymerase chain reaction (RT-PCR), PCR array, and alkaline phosphatase assay. An in vivo subcutaneous mouse model was used to investigate the effect on angio- and osteogenesis of VEGFA alone or in combination with BMP2, using microcomputed tomography (μCT), histology, immunohistochemistry, and immunofluorescence.

resultsCombined delivery of a lower ratio (1:3) of VEGFA and BMP2 (ad-BMP2 + VEGFA) led to upregulation of osteogenic and angiogenic genes in vitro at 3 and 14 days, compared with mono-delivery of VEGFA (ad-VEGFA) and other controls. In vivo, in a subcutaneous mouse model, both ad-VEGFA and ad-BMP2 + VEGFA scaffold explants exhibited increased angiogenesis at 2 weeks. Enhanced angiogenesis was largely related to the recruitment and differentiation of mouse progenitor cells to the endothelial lineage and, to a lesser extent, to endothelial differentiation of the implanted BMSC. μCT and histological analyses revealed enhanced de novo bone formation only in the ad-BMP2 + VEGFA group, corresponding at the molecular level to the upregulation of genes related to osteogenesis, such as ALPL, RUNX2, and SPP1.

conclusionsAlthough BMSC expressing VEGFA alone or in combination with BMP2 significantly induced angiogenesis, VEGFA alone failed to demonstrate osteogenic activity both in vitro and in vivo. These results not only call into question the use of VEGFA alone in bone regeneration, but also highlight the importance in BTE of appropriately formulated combined delivery of VEGFA and BMP2.

Indexed as

Cells, ImmobilizedMesenchymal Stem Cell TransplantationNeovascularization, PhysiologicOsteogenesisAdenoviridaeAnimalsBone Marrow CellsBone Morphogenetic Protein 2Genetic VectorsGene Transfer TechniquesHeterograftsHumansMesenchymal Stem CellsMiceMice, Inbred NODMice, SCIDBMP2 protein, humanBone Morphogenetic Protein 2Polyesterspoly(lactide)Vascular Endothelial Growth Factor AVEGFA protein, humanAngiogenesisBMP2 and VEGFABone regenerationGene deliveryMesenchymal stem cellScaffold

Identifiers

PMID29386057
PMCPMC5793460
OpenAlexW2785701598

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.